Sustained production of a soluble IGF-I receptor by gutless adenovirus-transduced host cells protects from tumor growth in the liver (Q39183606)

9 September 2017

Sustained production of a soluble IGF-I receptor by gutless adenovirus-transduced host cells protects from tumor growth in the liver (English)

1 reference

9 September 2017

1 reference

N Wang

1

1 reference

9 September 2017

Y Lu

2

1 reference

9 September 2017

M Pinard

3

1 reference

9 September 2017

A Pilotte

4

1 reference

9 September 2017

R Gilbert

5

1 reference

9 September 2017

B Massie

6

1 reference

9 September 2017

P Brodt

7

1 reference

9 September 2017

8 March 2013

1 reference

9 September 2017

1 reference

9 September 2017

20

1 reference

9 September 2017

4

1 reference

9 September 2017

229-236

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2013.10

9 September 2017

0 references

cites work

Survival after hepatic resection for colorectal metastases: a 10-year experience

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

The role of the IGF system in cancer growth and metastasis: overview and recent insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Molecular and cellular aspects of the insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Disrupting insulin-like growth factor signaling as a potential cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Targeting the insulin-like growth factor receptor-1R pathway for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Targeting the insulin-like growth factor axis for the development of novel therapeutics in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor Flk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Liver-directed gene transfer vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Long-Term Stable Expression of Human Apolipoprotein A-I Mediated by Helper-Dependent Adenovirus Gene Transfer Inhibits Atherosclerosis Progression and Remodels Atherosclerotic Plaques in a Mouse Model of Familial Hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Loss of tumorigenicity and metastatic potential in carcinoma cells expressing the extracellular domain of the type 1 insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Development of a suspension serum-free helper-dependent adenovirus production system and assessment of co-infection conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Dystrophin expression in muscle following gene transfer with a fully deleted ("gutted") adenovirus is markedly improved by trans-acting adenoviral gene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Helper-dependent adenoviral vectors for liver-directed gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor beta subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Preclinical studies for pharmacokinetics and biodistribution of Ad-stTRAIL, an adenovirus delivering secretable trimeric TRAIL for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Protein hormones and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

VEGF trap as a novel antiangiogenic treatment currently in clinical trials for cancer and eye diseases, and VelociGene- based discovery of the next generation of angiogenesis targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

inferred from DOI database lookup

7 January 2021

based on heuristic

Improved performance of a fully gutted adenovirus vector containing two full-length dystrophin cDNAs regulated by a strong promoter

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

inferred from DOI database lookup

7 January 2021

based on heuristic

Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.10

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2013.10

1 reference

9 September 2017

1 reference